Granite Point Capital Management, L.P. - RUBIUS THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 70 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.1%.

Links
Filings
EDGAR links
External links
Quarter-by-quarter ownership
Granite Point Capital Management, L.P. ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$667,000
+12.5%
36,8480.0%0.06%
-45.8%
Q4 2018$593,000
-79.2%
36,848
-69.0%
0.12%
-36.5%
Q3 2018$2,849,000–118,700–0.19%–
 Download
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Artal Group S.A. 2,042,666$440.00%
Tower Research Capital LLC (TRC) 25$00.00%
Baader Bank Aktiengesellschaft 73,420$1,2200.00%
Clarius Group, LLC 21,393$4560.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
STATE OF MICHIGAN RETIREMENT SYSTEM 640,000$13,6320.00%
ACADIAN ASSET MANAGEMENT LLC 179,676$20.00%
SIMPLEX TRADING, LLC 3,856$00.00%
View complete list of RUBIUS THERAPEUTICS INC shareholders